To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05201547
Title Endometrial Cancer Patientes MMR Deficient Comparing Chemotherapy vs Dostarlimab in First Line (DOMENICA)
Acronym DOMENICA
Recruitment Recruiting
Gender female
Phase Phase III
Variant Requirements Yes
Sponsors ARCAGY/ GINECO GROUP
Indications
Therapies
Age Groups: adult | senior
Covered Countries NZL | ITA | GBR | FRA | ESP | CAN | AUS